Achieve Life Sciences Inc (SP4P) — Cash Flow-to-Debt Ratio
Achieve Life Sciences Inc (SP4P) has a Cash Flow-to-Debt Ratio of -0.89x as of December 2025, meaning its operating cash flow of €-17.98 Million could theoretically repay -1% of its total liabilities (€20.27 Million) in one year. Explore cash flow conversion of Achieve Life Sciences Inc to assess how effectively this company generates cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Achieve Life Sciences Inc Cash Flow-to-Debt Ratio (2016–2025)
Historical debt coverage capacity for Achieve Life Sciences Inc across 10 annual periods. Also explore Achieve Life Sciences Inc (SP4P) total assets for the complete picture of this company's asset base.
Annual Cash Flow-to-Debt Ratio for Achieve Life Sciences Inc (2016–2025)
Year-by-year debt coverage analysis for Achieve Life Sciences Inc. For market capitalisation and broader financial context, see Achieve Life Sciences Inc market capitalisation.
| Year | CF-to-Debt Ratio | Operating CF (EUR) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -2.44x | €-49.47 Million | €20.27 Million | ▼ -45.4% |
| 2024 | -1.68x | €-29.77 Million | €17.73 Million | ▼ -42.8% |
| 2023 | -1.18x | €-24.48 Million | €20.82 Million | ▲ +32.1% |
| 2022 | -1.73x | €-37.55 Million | €21.67 Million | ▼ -14.6% |
| 2021 | -1.51x | €-29.44 Million | €19.47 Million | ▲ +66.2% |
| 2020 | -4.47x | €-13.47 Million | €3.01 Million | ▲ +11.0% |
| 2019 | -5.03x | €-15.22 Million | €3.03 Million | ▼ -55.3% |
| 2018 | -3.24x | €-10.62 Million | €3.28 Million | ▲ +28.5% |
| 2017 | -4.52x | €-9.11 Million | €2.01 Million | ▼ -18946.0% |
| 2016 | -0.02x | €-202.00K | €8.50 Million | — |